Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
February 2005
We sent the following press release out today. Nexa Orthopedics, Inc. and HealthpointCapital Announce Purchase of Futura Biomedical, L.L.C. Nexa Orthopedics, Inc. is focused on developing innovative products to meet the unmet clinical needs of the extremity surgeon. New York,... more
Overwhelmed with all the education opportunities? Join the club. Good news for you, though - the HealthpointCapital research team has whittled down the program to 26 of the most controversial and best-hosted side sessions. Minimally Invasive Breaks Out Every year... more
HealthpointCapital, LLC research has initiated a new program of making our market forecasts of the several orthopedic medical device segments available to our subscribers. This article, the first of a series, summarizes our spine market forecast which comes from our... more
This morning, newly sworn in House and Human Service Secretary Mike Leavitt announced the creation of a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they are on the market. The Board will continually update physicians and... more
On Tuesday of last week, Genzyme Corporation (Nasdaq: GENZ) announced another foray into the world of cartilage repair with the acquisition of Germany's Verigen AG. Founded only in 1999, Verigen has been selling a proprietary cell therapy system for cartilage... more
It's here again, the annual AAOS conference. Thousands are ready to descend on Washington, D.C. the week of February 21st to learn of new surgical techniques, new products and to develop business and relationships. While it is hard to predict... more
Last week, Kyphon Inc. (Nasdaq: KYPH) met or exceeded analysts' expectations and announced net sales of $62.4 million for 4Q:04, an increase of 57% over the $39.7 million in net sales reported in 4Q:03 Earnings per fully-diluted share for 4Q:04... more
Last week, Canadian's Millenium Biologix Corp. (TSX: MBC), a biomedical company that develops and supplies minimally invasive devices and skeletal tissue regeneration products, reported its 3Q:05 and its twelve months results for December 31, 2004. Millenium Biologix Corporation is the... more
Wright reported both 4Q:04 and year-end 2004 financials on Thursday evening. 4Q:04 revenues totaled $77.7 million a 13% increase over 4Q:03 revenues and at the upper end of management's previous guidance of revenues of $76-$78 million. Revenues for the year... more
After a strong report from Zimmer earlier in the week, Smith & Nephew followed suit on Thursday. SNN reported revenues totaled £332 million for the 4Q:04 which was a 14% increase over the 4Q:03 on a constant currency basis. Earnings-per-share... more
Synthes, Inc. (SYST.VX), a worldwide maker, developer and distributor of orthopedic trauma implants, biological devices and spinal hardware, reported financial results for fourth-quarter and fiscal year 2004 on January 20/2005. SYST reported sales for 4Q:04 at $469.4 million, an increase... more
After Stryker and DePuy reported somewhat modest financial reports two weeks ago, it seemed like many industry analysts and experts were talking of a potential slowdown in orthopedic growth. Then Zimmer reported revenues of $800 million for the 4Q:04 which... more
Complete Archive
|
